Post-earnings recap
Reported
Tue, Aug 6, 2013
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ACADIA Pharmaceuticals reported a loss of $0.11 per share, missing expectations. The stock reacted negatively, dropping 4.21%. The lack of revenue data and management commentary leaves investors without additional context for the performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.11 | N/A | -25.00% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.